For a long time, Semaglutide has served as prescription medication to keep type 2 diabetes in check. However, due to its weight loss effects when paired with a proper diet and exercise routine, compounded Semaglutide also has taken on new applications, more so concerning weight management. This is a trend that has been catching on, vindicated by studies that have shown that most people, on average, lose about 35 pounds after 17 months of use. Today, we charter a course into the future of compounded Semaglutide to unearth exciting trends and innovations:
Patient-specific Semaglutide formulation
Gone are the days of generic drug solutions for patients. Compounding pharmacies have seen to that. And in are the days of more patient-centric Semaglutide therapy.
These pharmacies are creating personalized formulations on demand, taking into account an individual’s unique requirements such as:
- Weight or body size
- Desired weight loss goals
- Allergies and so on
This tailor-fit personalization of Semaglutide therapy elevates drug efficacy, expedites weight loss, and helps you get to the body of your dreams even faster. It is spearheading the charge into a new era that’s all about precision medicine. Moreover, the ability to whip up Semaglutide from raw ingredients without having to rely on retailers also means greater affordability for patients.
AI to predict drug interactions for Semaglutide therapy
The AI in pharma market is on the fast track to growth, displaying a mammoth CAGR of 29.4% which has set it on course to surpass a value of $9.2 billion by 2030. This simply shows the continuing influence of artificial intelligence on the pharma workflow.
Companies such as ExactCure are offering revolutionary new technology that allows pharmacies to determine how patients will respond or react to medication. Doing so alleviates trial and error, ensuring precision medicine that’s more personalized than ever
This innovation may prove especially handy when it comes to compounded Semaglutide Therapy, given how some patients can react adversely to the medicine. Using such AI-driven technologies, pharmacists may be able to more accurately anticipate outcomes and find proper dosage strengths for each individual.
3-D printing of Semaglutide drugs
This is more of an innovation that’s still in the pipeline than a trend, but it’s still one that’s worth our attention. A while ago, computer scientists from the University of California came up with an amazing idea- using 3D printers to print pills.
Before we can get into how 3-D printing works in this, we should first of all think about the two popular routes of administration for the drug namely oral ingestion (through tablets) and subcutaneous (via injections).
Now, any compounding pharmacy will tell you that’s easy to control the concentration of active ingredients when you’re dealing with intravenous infusion (injection). However, that can be a particularly hard nut to crack where Semaglutide tablets are concerned. 3D technology may make a big difference in the latter case, providing a more effortless way to combine these ingredients at the right concentration levels.
Overall, the potential benefits of using 3-D printing for compounded Semaglutide therapy include:
- More accurate dosing
- Greater affordability
- Easier to meet pattern preferences (in terms of color, shape, and size of the tablet)
- Better medication adherence
While no pharmacies are using 3D printing technology to print compounded Semaglutide pills just yet, it’s an innovation that our assisted living pharmacy believes will find its way into a pharmacist’s workflow soon.
Blockchain technology for authenticity checks
Counterfeit and substandard drugs are a huge problem in the pharmaceutical industry. In some developed countries, statistics by the National Institutes of Health seem to suggest that 5 in 10 Semaglutide drugs may be counterfeit or inferior, although the global average stands at about 10.5%.
Counterfeit Semaglutide is not something that we can easily detect without having to go under the microscope. Pharma players are today turning to blockchain technology to solve this challenge. Through smart contracts and digital security features unique to each authentic batch, it becomes possible for a compounding pharmacy Florida, for example, to verify the legitimacy of ingredients from China, for instance.
These security systems, if you will, are managed via cloud platforms, ensuring real-time monitoring of these ingredients across the supply chain. In a nutshell, the involvement of blockchain technology will mean having to deal with fewer knockoffs when it comes to compounded Semaglutide therapy.
Use of digital pills for Semaglutide therapy
Digital pills involve the idea of combining medication with ingestible electronics, helping you to keep up with your medication routine. They are viewed as a more effortless way to track medication adherence compared to smartphone medication logging apps.
With many people often on compounded Semaglutide therapy for at least 68 weeks, digital pills represent a high-potential innovation to ensure patients stay on track. Some potential advantages of using digital pills for Semaglutide therapy include:
- Expediting refill processes
- Easier to keep caregivers/healthcare providers in the loop (For instance, a physician can get an alert in case you miss a dose)
- Ability to track and control drug use
However, certain issues around digital pills have ensured a slow adoption rate. Most notably, there are concerns about patient autonomy. Additionally, the technology is quite frankly expensive so our money is on digital pills not taking off. But they still make for an interesting innovation worth your read.
Roping in pharmacogenomics
Genetics plays a key role in our weight. Research by Harvard Health uncovered that certain genetic combinations can predispose the risk of obesity by up to 80%. Beyond weight, genetics also plays a considerable role in how our bodies react to medication such as compounded Semaglutide, for example.
Pharmacogenomics is the ability to modify how a drug works in relation to one’s genetic code. Genetic testing might be a preliminary phase of compounded Semaglutide therapy in the coming years, in a bid to elevate the quality of precision medication and consequently weight loss outcomes.
The wheels of innovation will keep turning
The future of compounded Semaglutide therapy may be influenced by the popularity of artificial intelligence, digital pills, 3D printing, and pharmacogenomics to name a few. We’re bound to witness the combination of pharmacy and even more innovative technologies over time. Our compounding pharmacy Florida takes great pride in providing compounded solutions that stay ahead of the curve. Schedule a call with us to discuss how we can tailor cutting-edge compounded weight loss solutions just for you.